Winning in Rx Licensing
Executive Summary
Recent evidence suggests that the fastest growing companies are often among the best at licensing. Best practice companies have created a systematic licensing process running from deal sourcing through post-deal integration, rather than depending on the efforts of a few key licensing people.
You may also be interested in...
Pipeline Watch: Phase III Readouts For Daridorexant And Efbemalenograstim
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: New CEOs At Ipsen, Herantis Pharma And Oncopetides
BeiGene gets a new chief business executive and there are new CMOs at Cellectar Biopharma, MacroGenics and Reata Pharmaceuticals.
EU Checks Pharma’s Appetite To Share Market Launch Intentions
A new EU pilot will help drug regulators and policymakers understand the factors influencing the uneven availability of centrally authorized medicines in the member states.
Need a specific report? 1000+ reports available
Buy Reports